Loading...
Loading...
Browse all stories on DeepNewz
VisitMost cited technology in Human Cell Atlas papers by end of 2024?
Single-cell RNA sequencing • 25%
CRISPR technology • 25%
3D bioprinting • 25%
Other • 25%
Analysis of citations in published research papers
3,600 Scientists from 100 Countries Map Every Human Cell, Revolutionizing Healthcare
Nov 20, 2024, 05:01 PM
The Human Cell Atlas initiative, involving over 3,600 scientists from 100 countries, has made significant strides in mapping every cell type in the human body, from development to old age. This monumental project, likened to a 'Google Maps' for biology, has published a collection of more than 40 peer-reviewed papers in Nature Portfolio journals, providing detailed maps of human tissues and systems throughout life. These maps are transforming our understanding of human biology, with implications for health, disease, and medical research. The project has been described as a 'remarkable achievement' and is expected to revolutionize healthcare by providing a comprehensive cellular atlas of our 37 trillion cells. Additionally, the initiative has produced 3D maps of cancer, offering insights into tumor development, spread, and treatment responses.
View original story
Advanced Computing • 25%
Artificial Intelligence • 25%
Citizen Science Contributions • 25%
Other • 25%
Human gene editing • 25%
Animal models • 25%
Plant genomics • 25%
Microbial engineering • 25%
Cancer treatment advancements • 25%
Rare disease understanding • 25%
Regenerative medicine • 25%
Other • 25%
Neuroscience • 25%
Immunology • 25%
Cardiology • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
AI/ML algorithms • 25%
Advanced imaging techniques • 25%
Crowdsourced validation • 25%
Other • 25%
PacBio sequencing • 25%
Nanopore sequencing • 25%
Illumina sequencing • 25%
Other • 25%
Nature • 25%
Science • 25%
Cell • 25%
Other • 25%
Illumina • 25%
Thermo Fisher Scientific • 25%
Bio-Rad Laboratories • 25%
Other • 25%
Other • 25%
Cancer • 25%
Cardiovascular Diseases • 25%
Neurodegenerative Diseases • 25%